Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(Propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-one → Methyl 1-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}cyclobutanecarboxylate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(Propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-one | HCID 1653580 | — |
| 반응물 | Methyl 1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidin-1-yl)methyl]cyclobutanecarboxylate | HCID 67233391 | — |
| 생성물 | Methyl 1-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}cyclobutanecarboxylate | HCID 68584360 | — |
반응 단계
The title compound was prepared according to the procedure described in Step 6 of Example 1 from 1-isopropyl-1,3-dihydro-2H-benzimidazol-2-one and methyl 1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidin-1-yl)methyl]cyclobutanecarboxylate (step 2 of Example 7).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07595329B2 |
| 출처 데이터셋 | uspto-grants-2009_09 |
| ORD ID | ord-412121d8edf7461f8873ed959156820f |
| 출처 메모 | uspto-grants-2009_09 |